Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov;2(1):573-97.
doi: 10.1146/annurev-virology-100114-055226. Epub 2015 Sep 2.

Innate and Adaptive Immune Regulation During Chronic Viral Infections

Affiliations
Review

Innate and Adaptive Immune Regulation During Chronic Viral Infections

Elina I Zuniga et al. Annu Rev Virol. 2015 Nov.

Abstract

Chronic viral infections represent a unique challenge to the infected host. Persistently replicating viruses outcompete or subvert the initial antiviral response, allowing the establishment of chronic infections that result in continuous stimulation of both the innate and adaptive immune compartments. This causes a profound reprogramming of the host immune system, including attenuation and persistent low levels of type I interferons, progressive loss (or exhaustion) of CD8(+) T cell functions, and specialization of CD4(+) T cells to produce interleukin-21 and promote antibody-mediated immunity and immune regulation. Epigenetic, transcriptional, posttranscriptional, and metabolic changes underlie this adaptation or recalibration of immune cells to the emerging new environment in order to strike an often imperfect balance between the host and the infectious pathogen. In this review we discuss the common immunological hallmarks observed across a range of different persistently replicating viruses and host species, the underlying molecular mechanisms, and the biological and clinical implications.

Keywords: HCV; HIV; LCMV; T cells; chronic viral infection; interferon.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Type I interferon (IFN-I) dynamics and opposing effects during chronic viral infections. Upon infection with most persistent viruses, IFN-I are powerfully and systemically induced; this initial response is rapidly attenuated, although low IFN-I and IFN-I-stimulated gene (ISG) levels still persist in multiple cells and tissues. Several innate cells, including macrophages, conventional dendritic cells (cDCs), and plasmacytoid dendritic cells (pDCs) (and possibly nonhematopoietic cells, which are not depicted), sense viral products via pattern-recognition receptors (PRRs) to contribute to IFN-I levels. Although they are the most powerful IFN-I producers early after challenge with persistent viruses, pDCs show an impaired capacity to produce IFN-I during chronic stages of lymphocytic choriomeningitis virus (LCMV), human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV) infections. IFN-I exert both beneficial and detrimental effects on immune responses and viral control, which appear conserved among different persistent infections. The relative degree and impact on viral replication of such opposing IFN-I effects may vary for individual cases.
Figure 2
Figure 2
CD4+ and CD8+ T cell adaptation during chronic viral infections. Persistent antigen drives recalibration of T cell responsiveness by inducing transcriptional (e.g., reduced TBET and increased EOMES), epigenetic (e.g., DNA methylation of the PD1 gene locus), and metabolic (e.g., reduced glycolysis and spare respiratory capacity) changes that result in limited functional properties [e.g., CD8+ T cell cytotoxicity, T helper 1 (Th1) cytokine production] and/or functional specialization [e.g., IL-21 elevation and T follicular helper (TFH) cell differentiation]. Recent studies have begun uncovering the heterogeneity in the CD4+ and CD8+ T cell compartment during chronic viral infection. Importantly, although they are partially hyporesponsive, CD4+ and CD8+ T cells are essential to control persistently replicating viruses in mice and humans.

References

    1. Kassiotis G. Endogenous retroviruses and the development of cancer. J Immunol. 2014;192:1343–49. - PMC - PubMed
    1. Virgin HW, Wherry EJ, Ahmed R. Redefining chronic viral infection. Cell. 2009;138:30–50. - PubMed
    1. Aoshi T, Koyama S, Kobiyama K, Akira S, Ishii KJ. Innate and adaptive immune responses to viral infection and vaccination. Curr Opin Virol. 2011;1:226–32. - PubMed
    1. Garcia-Sastre A, Biron CA. Type 1 interferons and the virus-host relationship: a lesson in détente. Science. 2006;312:879–82. - PubMed
    1. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol. 2009;83:3719–33. - PMC - PubMed

Publication types